We are live on ! Find out more
MET.PRA icon

MetLife Series A Preferred Stock

6 hedge funds and large institutions have $4.26M invested in MetLife Series A Preferred Stock in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more capital inflows, than outflows

Capital inflows: $49.9K | Capital outflows: $21.5K

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 6 → 6 (0)

0% more ownership

Funds ownership: 0.75% → 0.76% (+0%)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MET.PRA Hedge Fund Activity: Q1 2022 in Review

6 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in MetLife Series A Preferred Stock (MET.PRA) for Q1 2022, worth a combined $4.26M — down 7.9% from $4.62M a quarter earlier.

Fund positioning in MET.PRA was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was PNC Financial Services Group, adding an estimated $42.8K. The largest seller was Tower Bridge Advisors, cutting an estimated $21.5K.

  • 6 institutional investors held MetLife Series A Preferred Stock (MET.PRA) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $4.26M of MetLife Series A Preferred Stock stock for Q1 2022, down 7.9% quarter-over-quarter.
  • 0 funds opened new MetLife Series A Preferred Stock positions in Q1 2022 and 0 closed out.
  • The largest MetLife Series A Preferred Stock buyer in Q1 2022 was PNC Financial Services Group, an estimated $42.8K added.
  • The largest MetLife Series A Preferred Stock seller in Q1 2022 was Tower Bridge Advisors, an estimated $21.5K sold.

Based on aggregated 13F filings for Q1 2022.